Pulmonary Arterial Hypertension (PAH) Market Was Valued at US$4.04 Billion in 2013 and Is Expected Reach US$5.19 Billion in 2020
The global pulmonary arterial hypertension market is expected to rise proportionate to the rise in the number of heart failures. Pulmonary arterial hypertension is characterized by restrained blood flow via the pulmonary arteries, which leads to a constant increase in pulmonary vascular resistance and finally failure of the right side of the heart. PAH is one of five groups of pulmonary hypertension, as described by the World Health Organization (WHO). PAH develops due to the narrowing, blocking, and thickening of...
View full press release